Core Viewpoint - 圣贝拉有限公司 (02508.HK) was listed on the Hong Kong Stock Exchange, closing at HKD 8.80, a rise of 33.74% from its final offering price of HKD 6.580 [1][3]. Summary by Relevant Sections Share Issuance and Capital Structure - The total number of shares offered globally by 圣贝拉 was 109,733,000, with 7,710,000 shares allocated for the Hong Kong public offering and 62,023,000 shares for international offering [1][2]. - At the time of listing, the total number of issued shares was 609,733,000 [2]. Financial Details - The total proceeds from the offering amounted to HKD 722.04 million, with net proceeds of HKD 629.95 million after deducting estimated listing expenses of HKD 92.09 million [3][4]. - The company plans to allocate approximately 29% of the net proceeds to expand its postpartum care network, 37% for launching new services and products, 6% for training family care professionals, 18% for research and development activities, and 9% for working capital and other general corporate purposes [4]. Financial Performance - 圣贝拉's revenue for the years 2022, 2023, and 2024 is projected to be RMB 471.52 million, RMB 559.91 million, and RMB 798.67 million, respectively [6][7]. - The company reported losses of RMB 411.58 million in 2022, RMB 238.89 million in 2023, and an expected loss of RMB 543.28 million in 2024 [6][7]. - The net cash flow from operating activities for the same years was RMB 24.11 million, RMB 56.70 million, and RMB 49.08 million, respectively [8].
圣贝拉港股上市募7.2亿港元首日涨34% 近三年均亏损